Don't Throw Out the Baby With the Bathwater: On Optimizing Cure and Reducing Toxicity in Hodgkin's Lymphoma
- 1 February 2006
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (4), 544-548
- https://doi.org/10.1200/jco.2005.04.4396
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Combined-Modality Therapy Versus Radiotherapy Alone for Treatment of Early-Stage Hodgkin's Disease: Cure Balanced Against ComplicationsJournal of Clinical Oncology, 2006
- Bleomycin Pulmonary Toxicity Has a Negative Impact on the Outcome of Patients With Hodgkin's LymphomaJournal of Clinical Oncology, 2005
- Chemotherapy Alone for Early Hodgkin's Lymphoma: An Emerging OptionJournal of Clinical Oncology, 2005
- Hodgkin disease: the sword of Damocles resheathedBlood, 2004
- Severe Pulmonary Toxicity in Patients With Advanced-Stage Hodgkin's Disease Treated With a Modified Bleomycin, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, Prednisone, and Gemcitabine (BEACOPP) Regimen Is Probably Related to the Combination of Gemcitabine and Bleomycin: A Report of the German Hodgkin's Lymphoma Study GroupJournal of Clinical Oncology, 2004
- Consolidation Radiation After Complete Remission in Hodgkin's Disease Following Six Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Chemotherapy: Is There a Need?Journal of Clinical Oncology, 2004
- Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: Results of the HD8 Trial of the German Hodgkin’s Lymphoma Study GroupJournal of Clinical Oncology, 2003
- Secondary Myeloid Leukemia and Myelodysplastic Syndromes in Patients Treated for Hodgkin’s Disease: A Report From the German Hodgkin’s Lymphoma Study GroupJournal of Clinical Oncology, 2003
- Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin diseaseCancer, 2003
- Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup TrialJournal of Clinical Oncology, 2003